UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

~~SECURITIES~~Washington, ~~AND~~D.C. ~~EXCHANGE COMMISSION~~20549

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant Toto Section 13 orOR 15(d) ~~of the Securities Exchange Act of 1934~~

~~Date~~ of ~~Report: February~~The 2,Securities ~~2015~~Exchange Act of 1934

~~AQUENTIUM,~~Date ~~INC.~~of Report (~~Exact~~Date ~~Name~~ of ~~Registrant~~earliest asevent ~~Specified~~reported): inMarch ~~Charter~~7, 2016 (March 3, 2016)

AQUENTIUM, INC.

(Exact name of registrant as specified in its charter)

Delaware		000-23402		11-2863244
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

29743 Vacation Drive Canyon Lake, CA		92587
(Address of principal executive offices)		(Zip Code)

20743 VACATION DRIVE

~~Registrant’s~~CANYON ~~telephone number~~LAKE, ~~including~~CA ~~area code:~~92587 ~~(951) 244-8208~~

~~______________________________________________~~(Address of principal executive offices) (Zip Code)

~~(Former~~Registrants' ~~Name~~telephone ~~or former address~~number, ifincluding ~~changed~~area ~~since~~code: ~~last report.~~(951) 383-4546

~~Check~~Not the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):applicable

¨(Former ~~Written~~name ~~communications~~or ~~pursuant~~former toaddress, ~~Rule~~if ~~425~~changed ~~under~~since ~~the~~last ~~Securities Act (17 CFR 230.425~~report)

¨Check ~~Soliciting~~the ~~material~~appropriate ~~pursuant~~box tobelow ~~Rule~~if ~~14a~~the Form 8-12K ~~under~~filing is intended to simultaneously satisfy the ~~Exchange~~filing ~~Act~~obligation ~~(17~~of ~~CFR~~the ~~240.14-12)~~registrant under any of the following provisions:

¨o Written ~~Pre-commencement~~ communications pursuant to Rule 425 ~~14d-2(b)~~ under the ~~Exchange~~Securities Act (17 CFR ~~240~~230.~~14d-2(b~~425))

¨o Soliciting ~~Pre-commencement~~material ~~communications~~ pursuant to Rule 13 14a-~~e-4(c)~~12 under the Exchange Act (17 CFR 240.~~13e~~14a-~~4(c~~12))

~~Item~~o Pre-commencement ~~1.01~~communications pursuant to Rule 14d-2(b) under ~~Entry~~the ~~into~~Exchange aAct ~~Material~~(17 ~~Definitive~~CFR ~~Agreement~~240.14d-2(b))

Ono Pre-commencement ~~February~~communications 2,pursuant ~~2015 Aquentium, Inc. and Biofitt Inc. finalized a consulting agreement that will allow Aquentium~~ to ~~acquire~~Rule 13e-4(c) under ~~and own twenty percent of Biofitt’s common shares in exchange for consulting services to~~ the ~~company.~~Exchange ~~Biofitt,~~Act ~~Inc.~~(17 isCFR ~~a Colorado corporation that was incorporated in January 2015 to manufacture, market and sell its own brand of energy and vitamin drinks~~240. `13e-4(c))

~~Biofitt,~~ITEM ~~Inc~~2.01 ~~intends~~COMPLETION toOF ~~capitalize~~ACQUISITION onOR ~~the~~DISPOSITION ~~opportunities~~OF ~~in the Health and Energy Drink consumer markets by creating “Advanced Biofitt Energy/Vitamin” drinks & other products~~ASSETS.

~~Biofitt,~~FORMATION ~~Inc.~~OF ~~also~~WHOLLY ~~plans~~OWNED to launch a new packaging method Pocket Shots (Sachets) which eases the problems of carrying and disposing of bulky, round, plastic bottles. While the products will still be available in plastic bottles, the sachets will fit in one’s pocket, and pack more densely and discretely in your luggage, fitness bag, business briefcase, purse, etc. This packaging method also allows denser packaging which reduces shipping and distribution costs, while improving placement and display in convenience store outlets.SUBSIDAIRY

~~Biofitt,~~On ~~Inc.~~March is3, ~~planning~~2016, toAQUENTIUM, ~~raise~~INC. upformed toa ~~five~~wholly ~~million~~owned ~~dollars~~subsidiary tonamed ~~establish~~L3 ~~manufacturing~~MEDICAL, ~~for its beverage products and for co-packing operations for other beverage processors~~INC.

~~Biofitt~~L3 MEDICAL, ~~Inc~~INC. ~~plans~~was oncreated ~~opening~~for ~~its~~the ~~manufacturing~~purpose ~~facilities~~owning inand ~~Indonesia~~operating ~~and~~numerous health care clinics in the ~~Philippines~~United States. The L3 MEDICAL healthcare clinics will be focused on utilizing low level laser therapy for individuals suffering from body pain.

2L.A.S.E.R. (Light Amplification by Stimulated Emission of Radiation) is a name for a type of intense radiation of the light spectrum. A laser is a beam of light in which high energies can be concentrated. Laser light has unique physical properties, which other types of light do not have. These are coherence and monochromaticity. These are what makes laser light is so effective compared to other kinds of light in the field of pain reduction and healing.

~~SIGNATURE~~Laser therapy (also known as phototherapy and low level laser therapy) involves the application of low power coherent light to injuries and lesions to stimulate healing and reduce pain. It is used to increase the speed, quality and strength of tissue repair, resolve inflammation and give pain relief.

~~Pursuant~~Laser therapy has been found to ~~the~~offer ~~requirements~~superior ofhealing ~~the~~and ~~Securities~~pain ~~Exchange~~relieving ~~Act~~effects ofcompared ~~1934~~to other electrotherapeutic modalities such as ultrasound, especially in dealing with chronic problems and in the ~~Registrant~~early ~~has~~stages ~~duly~~of ~~caused~~acute ~~this~~injuries. ~~report~~Laser totherapy beis ~~signed~~a oncomplete ~~its~~system ~~behalf~~of bytreating ~~the~~muscle, ~~undersigned~~tendon, ~~hereunto~~ligament, ~~duly~~connective ~~authorized~~tissue, bone, nerve, and dermal tissues in a non-invasive, drug-free modality.

	AQUENTIUM, INC.
Dated: February 5, 2015	By:	/s/ Mark Taggatz
		Name: Mark Taggatz
		Title: President

3SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AQUENTIUM, INC.

Dated: March 7, 2016	By:	/s/ Mark Taggatz
		Name: Mark Taggatz
		Title: President

Filing Compare · AQUENTIUM INC